BioSpace News Archive

Genetic engineering is a branch of biotechnology that deals with gene modifications or changes in genetic makeup. By using prolonged tissue culture in genetic engineering, viruses can be attenuated or modified.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global dental infection control products market to see significant growth d during 2020-2030.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global apheresis market is projected to grow by 2x during the forecast period between 2020 to 2025, estimates Fact.MR.

Innate Pharma SA announced that the first patient was dosed in a Phase 1/2 clinical trial, evaluating IPH6101/SAR443579, the first NKp46/CD16-based NK cell engager, in patients with relapsed or refractory acute myeloid leukemia, B-cell acute lymphoblastic leukemia or high risk-myelodysplastic syndrome.

Nicox SA, an international ophthalmology company, announced that the first patient has been screened in China in the ongoing Denali Phase 3 clinical trial, opening the way for New Drug Application submissions in both the United States and China for NCX 470, Nicox’s lead clinical product candidate in glaucoma.

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces ensifentrine met all safety objectives in a thorough QT study designed to evaluate effects, if any, of ensifentrine on cardiac conduction in healthy individuals.

Alligator Bioscience announced an update on the on-going clinical Phase I trial with the 4-1BB drug candidate ATOR-1017, which is developed as a tumor-directed therapy for metastatic cancer.

Lung cancer can be broadly classified into two categories such as non-small cell lung cancer and small cell lung cancer.

Electronic devices are increasingly used for therapy, diagnosis, and rehabilitation in the field of medicine.

Drugs are the number one cause of premature death across the world and despite tight security measures at the borders, a number of governments are failing to contain this expanding issue.